[144] Axsome Therapeutics, Inc SEC Filing

Rhea-AI Filing Summary

Insider notice of proposed sale: This Form 144 reports a proposed sale of 9,127 shares of common stock of Axsome Therapeutics, Inc. via Charles Schwab & Co., Inc. valued at $1,141,529.00. The filing shows the shares were acquired and are proposed to be sold on 09/05/2025 following an employee stock option exercise and that payment was handled by broker payment for cashless exercise. The filing indicates there were 49,901,487 shares outstanding and names NASDAQ as the exchange for the sale. No securities of the issuer were reported sold by the filer in the past three months and other standard Form 144 declarations and signature statements are present.

Insights

Securities Analyst

TL;DR: Routine insider notice of sale following an option exercise; provides transaction details but no broader company disclosures.

The filing documents an insider proposing to sell 9,127 common shares acquired on the same date via an employee stock option exercise, with the transaction handled by Charles Schwab & Co. as a cashless exercise and the sale listed for NASDAQ. The notice includes the aggregate market value reported at $1,141,529.00 and the total shares outstanding reported as 49,901,487. There are no reported sales by this person in the prior three months. This is a standard Rule 144 notice fulfilling disclosure requirements; it does not provide information on company performance, disclosures, or motivations beyond the mechanics of this private transaction.

Corporate Governance Specialist

TL;DR: Compliance-focused filing documenting an internal, compensatory-origin sale; not indicative of governance event by itself.

The form indicates the shares stem from an employee stock option exercise and the filer affirms the absence of undisclosed material adverse information as required by the notice. The filing supplies broker, quantity, valuation, acquisition date, and sale date details. As a procedural disclosure under Rule 144, it meets regulatory notification expectations but does not, on its face, signal a governance or disclosure issue.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	9127	1141529.00	49901487	09/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Employee Stock Option Exercise	Axsome Therapeutics, Inc.			9127	09/05/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 filed for Axsome Therapeutics (AXSM) disclose?

The filing discloses a proposed sale of 9,127 common shares acquired and to be sold on 09/05/2025, via Charles Schwab & Co., with an aggregate market value of $1,141,529.00.

What was the nature of acquisition for the shares in the AXSM Form 144?

The shares were acquired through an employee stock option exercise and the payment method is listed as broker payment for cashless exercise.

Does the filing report prior sales by the filer in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are named in the AXSM Form 144?

The broker named is Charles Schwab & Co., Inc. and the exchange listed for the sale is NASDAQ.

What representations does the filer make in the Form 144?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed and includes the standard Form 144 signature/attention statements.